Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.
Please provide your email address to receive an email when new articles are posted on . The classification system associated with prenatally diagnosed osteogenesis imperfecta may be outdated. Modern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback